Showing results (31-40 of 57) with videos related to

Sort By:
Pageof 6
Journal of Medical Virology|July 27, 1999
Nucleotide sequence of thymidine kinase gene of sequential acyclovir-resistant herpes simplex virus type 1 isolates recovered from a child with Wiskott-Aldrich syndrome: evidence for reactivation of acyclovir-resistant herpes simplex virusM Saijo, T Suzutani, K Itoh, et al.
The Japanese Journal of Antibiotics|November 1, 1991
[Flomoxef in neonates and young infants; clinical efficacy, pharmacokinetic evaluation and effect on the intestinal bacterial flora]K Fujita, K Murono, M Saijyo, et al.
The Japanese Journal of Antibiotics|December 1, 1989
[Clinical and pharmacokinetic evaluation of cefmenoxime in neonates and young infants]K Fujita, K Murono, H Sakata, et al.
European Journal of Pediatrics|January 1, 1993
Molecular genetics of human androgen insensitivityT R Brown, P A Scherer, Y T Chang, et al.
The Japanese Journal of Antibiotics|August 1, 1983
[Clinical efficacy and pharmacokinetics of cefpiramide in children]K Fujita, H Sakata, K Murono, et al.
Clinical Genetics|January 15, 2008
Skewed X chromosome inactivation failed to explain the normal phenotype of a carrier female with MECP2 mutation resulting in Rett syndromeS Takahashi, J Ohinata, Y Makita, et al.
The Japanese Journal of Antibiotics|July 1, 1989
[Overall clinical evaluation of cefpodoxime proxetil against infections in pediatric fields]R Fujii, H Meguro, O Arimasu, et al.
The Japanese Journal of Antibiotics|January 1, 1993
[Pharmacokinetic and clinical studies of cefditoren pivoxil in the pediatric field. Pediatric Study Group of ME1207]R Fujii, H Yoshioka, A Okuno, et al.
Kansenshogaku Zasshi. the Journal of the Japanese Association for Infectious Diseases|November 1, 1992
[Characteristics of group A streptococci isolated from children with non-suppurative complication or severe infection]K Fujita, K Murono, M Yoshikawa, et al.
The Japanese Journal of Antibiotics|March 1, 1990
[Pharmacokinetics and clinical studies on aztreonam in neonates and premature infants (the first report). Study on effectiveness and safety in mono-therapy with aztreonam. A study of aztreonam in the Perinatal Co-research Group]R Fuji, S Hashira, T Tajima, et al.
Pageof 6